PL3407890T3 - Preparat farmaceutyczny i jego zastosowanie w leczeniu wirusowego zapalenia krtani - Google Patents

Preparat farmaceutyczny i jego zastosowanie w leczeniu wirusowego zapalenia krtani

Info

Publication number
PL3407890T3
PL3407890T3 PL17700818.2T PL17700818T PL3407890T3 PL 3407890 T3 PL3407890 T3 PL 3407890T3 PL 17700818 T PL17700818 T PL 17700818T PL 3407890 T3 PL3407890 T3 PL 3407890T3
Authority
PL
Poland
Prior art keywords
pharmaceutical preparation
treating viral
viral laryngitis
laryngitis
treating
Prior art date
Application number
PL17700818.2T
Other languages
English (en)
Inventor
Peter Sommer
Nicola VAUBEL
Original Assignee
Peter Sommer
Nicola VAUBEL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peter Sommer, Nicola VAUBEL filed Critical Peter Sommer
Publication of PL3407890T3 publication Critical patent/PL3407890T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/38Silver; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024Esters of saccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728Hyaluronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534Mentha (mint)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38Albumins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PL17700818.2T 2016-01-27 2017-01-18 Preparat farmaceutyczny i jego zastosowanie w leczeniu wirusowego zapalenia krtani PL3407890T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE202016100357.1U DE202016100357U1 (de) 2016-01-27 2016-01-27 Pharmazeutische Zubereitung und deren Verwendung bei viralen, entzündlichen Erkrankungen der oberen Atemwege
PCT/EP2017/050938 WO2017129457A1 (de) 2016-01-27 2017-01-18 Pharmazeutische zubereitung und deren verwendung bei viralen, entzündlichen erkrankungen der oberen atemwege

Publications (1)

Publication Number Publication Date
PL3407890T3 true PL3407890T3 (pl) 2023-12-04

Family

ID=55644505

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17700818.2T PL3407890T3 (pl) 2016-01-27 2017-01-18 Preparat farmaceutyczny i jego zastosowanie w leczeniu wirusowego zapalenia krtani

Country Status (5)

Country Link
EP (1) EP3407890B1 (pl)
DE (1) DE202016100357U1 (pl)
ES (1) ES2957220T3 (pl)
PL (1) PL3407890T3 (pl)
WO (1) WO2017129457A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019046844A1 (en) * 2017-09-02 2019-03-07 Iview Therapeutics, Inc. PHARMACEUTICAL COMPOSITIONS FORMING IN SITU A GEL AND THEIR USES FOR SINUS DISEASES
IT202000025963A1 (it) * 2020-11-02 2022-05-02 Neilos S R L “composizione per la prevenzione e il trattamento di affezioni dell’apparato respiratorio”

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992018133A1 (en) * 1991-04-11 1992-10-29 Drore Eisen Method of treatment using steroid mouthwash
US5324718A (en) * 1992-07-14 1994-06-28 Thorsteinn Loftsson Cyclodextrin/drug complexation
ES2214135B1 (es) * 2003-02-21 2005-05-01 Laboratorios Kin S.A. Composicion para el tratamiento de la cavidad bucal y utilizaciones correspondientes.
US20100190735A1 (en) * 2006-03-28 2010-07-29 Myrex Pharmaceuticals Inc. Mouthwash and Method of Using Same for the Treatment of Mucositis or Stomatitis
ITFI20080035A1 (it) * 2008-02-26 2009-08-27 Italmed S R L Composizione odontoiatrica per la prevenzione ed il trattamento della stomatite e delle ulcerazoni della mucosa orale
EP2110116A1 (de) * 2008-04-14 2009-10-21 Tentan AG Wässrige antiseptische Zubereitung für den Mund- und Rachenraum
ITMI20120019A1 (it) * 2012-01-10 2013-07-11 Restituta Castellaccio Colluttorio
MX2015012141A (es) * 2013-03-15 2016-04-25 Api Genesis Llc Composiciones de polifenoles/flavonoides y metodos para formular productos de higiene bucal.

Also Published As

Publication number Publication date
EP3407890A1 (de) 2018-12-05
ES2957220T3 (es) 2024-01-15
EP3407890C0 (de) 2023-07-19
DE202016100357U1 (de) 2016-03-09
EP3407890B1 (de) 2023-07-19
WO2017129457A1 (de) 2017-08-03

Similar Documents

Publication Publication Date Title
IL263972A (en) Dihydropyranopyrimidines for the treatment of viral infections
IL254552A0 (en) Polycyclic carbamoylpyridone compounds and their pharmaceutical uses
ZA201705633B (en) A new quinoline derivative for use in the treatment and prevention of viral infections
PL3189101T3 (pl) Bimodalny polipropylen oraz sposób jego wytwarzania
SG11201708624YA (en) Therapeutic antibodies and uses thereof
IL249660B (en) Methods for treating hepatitis b virus and hepatitis d virus infections
ZA201802256B (en) Compounds and therapeutic uses thereof
ZA201806742B (en) Shaped savoury concentrate and process for the preparation thereof
GB201617064D0 (en) Compounds and their therapeutic use
IL258682B (en) Viral neoepitopes and their uses
IL264403A (en) Vortioxetine analogue and use and preparation thereof
IL257335A (en) A depdc1-derived peptide and a component containing it
PT3350150T (pt) 1,1-difeniletilenos substituídos por alcenilfenoxilo, processos para a sua preparação e sua utilização
SG10202106375UA (en) Pharmaceutical compositions and use thereof
PL3407890T3 (pl) Preparat farmaceutyczny i jego zastosowanie w leczeniu wirusowego zapalenia krtani
GB201519644D0 (en) Therapy and pharmaceutical composition
IL265617B (en) 1-phenylpropanone compounds and their use
GB201706600D0 (en) Virus preparations
SMT202100362T1 (it) Composizione farmaceutica comprendente darunavir e metodo per la preparazione
GB201507529D0 (en) Virus preparations
ZA201508930B (en) Pharmaceutical composition comprising darunavir and method for the preparation thereof
GB201615560D0 (en) Novel compounds and therapeutic uses thereof
GB201520019D0 (en) The genome and self-evolution of AI
GB201408046D0 (en) Virus preparations